New Key Statistics Module, Z-Score and F-Score
SZSE:300534 Key Ratios
Market Cap ¥ M | 2,393.39 |
Enterprise Value ¥ M | 2,162.34 |
P/E(ttm) | 37.57 |
PE Ratio without NRI | 37.39 |
Forward PE Ratio | -- |
Price/Book | 3.65 |
Price/Sales | 2.30 |
Price/Free Cash Flow | 28.59 |
Price/Owner Earnings | 98.64 |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 1,038.00 |
EPS (TTM) ¥ | 0.21 |
Beneish M-Score | -3.06 |
10-y EBITDA Growth Rate % | -4.10 |
5-y EBITDA Growth Rate % | 30.20 |
y-y EBITDA Growth Rate % | 4.70 |
EV-to-EBIT | 21.12 |
EV-to-EBITDA | 21.12 |
PEG | 1.24 |
Shares Outstanding M | 303.35 |
Net Margin (%) | 6.14 |
Operating Margin % | 9.94 |
Pre-tax Margin (%) | 9.46 |
Quick Ratio | 1.18 |
Current Ratio | 1.36 |
ROA % (ttm) | 4.78 |
ROE % (ttm) | 10.29 |
ROIC % (ttm) | 12.48 |
Dividend Yield % | -- |
Altman Z-Score | 3.44 |
SZSE:300534 Number of Guru Trades
SZSE:300534 Volume of Guru Trades
Gurus Latest Trades with SZSE:300534
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300534 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Insider Transactions
No Available Data